1.Femenia, T, Gomez-Galan, M, Lindskog, M, Magara, S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Res. 2012; 1476: 58–70.
2.Small, SA, Schobel, SA, Buxton, RB, Witter, MP, Barnes, CA. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 2011; 12(10): 585–601.
3.Bell-McGinty, S, Butters, MA, Meltzer, CC, Greer, PJ, Reynolds, CF 3rd, Becker, JT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry. 2002; 159(8): 1424–1427.
4.Bremner, JD, Narayan, M, Anderson, ER, Staib, LH, Miller, HL, Charney, DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000; 157(1): 115–118.
5.Frodl, TS, Koutsouleris, N, Bottlender, R, et al. Depression-related variation in brain morphology over 3 years: effects of stress? Arch Gen Psychiatry. 2008; 65(10): 1156–1165.
6.Sheline, YI, Gado, MH, Kraemer, HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003; 160(8): 1516–1518.
7.Videbech, P, Ravnkilde, B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004; 161(11): 1957–1966.
8.MacQueen, GM, Campbell, S, McEwen, BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A. 2003; 100(3): 1387–1392.
9.Gorwood, P, Corruble, E, Falissard, B, Goodwin, GM. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry. 2008; 165(6): 731–739.
10.Harvey, PO, Fossati, P, Pochon, JB, et al. Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage. 2005; 26(3): 860–869.
11.Walsh, ND, Williams, SC, Brammer, MJ, et al. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry. 2007; 62(11): 1236–1243.
12.Hammar, A, Ardal, G. Cognitive functioning in major depression—a summary. Front Hum Neurosci. 2009; 3: 26.
13.Lee, RS, Hermens, DF, Porter, MA, Redoblado-Hodge, MA. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord. 2012; 140(2): 113–124.
14.Porter, RJ, Bourke, C, Gallagher, P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry. 2007; 41(2): 115–128.
15.Hasselbalch, BJ, Knorr, U, Kessing, LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011; 134(1–3): 20–31.
16.Campbell, S, MacQueen, G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci. 2004; 29(6): 417–426.
17.Biringer, E, Rongve, A, Lund, A. A review of modern antidepressants’ effects on neurocognitive function. Cur Psychiatr Rev. 2009; 5(3): 164–174.
18.McIntyre, RS, Cha, DS, Soczynska, JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013; 30(6): 515–527.
19.Vythilingam, M, Vermetten, E, Anderson, GM, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry. 2004; 56(2): 101–112.
20.Fanselow, MS, Dong, HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010; 65(1): 7–19.
21.Moser, MB, Moser, EI. Functional differentiation in the hippocampus. Hippocampus. 1998; 8(6): 608–619.
22.Poppenk, J, Evensmoen, HR, Moscovitch, M, Nadel, L. Long-axis specialization of the human hippocampus. Trends Cogn Sci. 2013; 17(5): 230–240.
23.O’Leary, OF, Cryan, JF. A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis. Trends Pharmacol Sci. 2014; 35(12): 675–687.
24.Moser, E, Moser, MB, Andersen, P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci. 1993; 13(9): 3916–3925.
25.Pothuizen, HH, Zhang, WN, Jongen-Relo, AL, Feldon, J, Yee, BK. Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci. 2004; 19(3): 705–712.
26.Bannerman, DM, Grubb, M, Deacon, RM, Yee, BK, Feldon, J, Rawlins, JN. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res. 2003; 139(1–2): 197–213.
27.Bannerman, DM, Rawlins, JN, McHugh, SB, et al. Regional dissociations within the hippocampus—memory and anxiety. Neurosci Biobehav Rev. 2004; 28(3): 273–283.
28.Kjelstrup, KG, Tuvnes, FA, Steffenach, HA, Murison, R, Moser, EI, Moser, MB. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci U S A. 2002; 99(16): 10825–10830.
29.Rudy, JW, Matus-Amat, P. The ventral hippocampus supports a memory representation of context and contextual fear conditioning: implications for a unitary function of the hippocampus. Behav Neurosci. 2005; 119(1): 154–163.
30.Ramon y, Cajal S. Histologie du Systeme Nerveux de l’Homme et des Vertbré Vol II. Paris: Maloine; 1911.
31.Lorente de Nó, R. Studies of the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. Journal für Psychologie und Neurologie. 1934; 46: 113–177.
32.Lavenex, P. Functional anatomy, development and pathology of the hippocampus. In: Bartsch T ed. The Clinical Neurobiology of the Hippocampus: An Integrative View. Oxford, UK: Oxford University Press; 2012: 10–38.
33.Freund, TF, Buzsáki, G. Interneurons of the hippocampus. Hippocampus. 1996; 6(4): 347–470.
34.Parra, P, Gulyas, AI, Miles, R. How many subtypes of inhibitory cells in the hippocampus? Neuron. 1998; 20(5): 983–993.
35.Ribak, CE, Nitsch, R, Seress, L. Proportion of parvalbumin-positive basket cells in the GABAergic innervation of pyramidal and granule cells of the rat hippocampal formation. J Comp Neurol. 1990; 300(4): 449–461.
36.Sloviter, RS. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol. 1989; 280(2): 183–196.
37.Aznar, S, Qian, Z, Shah, R, Rahbek, B, Knudsen, GM. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res. 2003; 959(1): 58–67.
38.Gulyas, AI, Hajos, N, Freund, TF. Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J Neurosci. 1996; 16(10): 3397–3411.
39.Berumen, LC, Rodriguez, A, Miledi, R, Garcia-Alcocer, G. Serotonin receptors in hippocampus. ScientificWorldJournal. 2012; 2012: 823493.
40.Oleskevich, S, Descarries, L, Watkins, KC, Seguela, P, Daszuta, A. Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience. 1991; 42(3): 777–791.
41.Umbriaco, D, Garcia, S, Beaulieu, C, Descarries, L. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus. 1995; 5(6): 605–620.
42.Vizi, ES, Kiss, JP. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 1998; 8(6): 566–607.
43.Aghajanian, GK, Sanders-Bush, E. Serotonin. In: Davis KL, Charney D, Coyle JT, Nemeroff C eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott, Williams, & Wilkins; 2002.
44.Glennon, RA, Dukat, M, Westkaemper, RB. Serotonin receptor subtypes and ligands. In: Bloom FE, Kupfer DJ eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 2000.
45.Herrick-Davis, K. Functional significance of serotonin receptor dimerization. Exp Brain Res. 2013; 230(4): 375–386.
46.Gonzalez-Maeso, J, Ang, RL, Yuen, T, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature. 2008; 452(7183): 93–97.
47.Naumenko, VS, Popova, NK, Lacivita, E, Leopoldo, M, Ponimaskin, EG. Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders. CNS Neurosci Ther. 2014; 20(7): 582–590.
48.Jarrard, LE. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol. 1993; 60(1): 9–26.
49.Squire, LR. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev. 1992; 99(2): 195–231.
50.Knierim, JJ, Hamilton, DA. Framing spatial cognition: neural representations of proximal and distal frames of reference and their roles in navigation. Physiological Rev. 2011; 91(4): 1245–1279.
51.Luscher, C, Jan, LY, Stoffel, M, Malenka, RC, Nicoll, RA. G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron. 1997; 19(3): 687–695.
52.Pompeiano, M, Palacios, JM, Mengod, G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci. 1992; 12(2): 440–453.
53.Andrade, R, Nicoll, RA. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol. 1987; 394: 99–124.
54.Beck, SG, Clarke, WP, Goldfarb, J. Spiperone differentiates multiple 5-hydroxytryptamine responses in rat hippocampal slices in vitro. Eur J Pharmacol. 1985; 116(1–2): 195–197.
55.Chaput, Y, Araneda, RC, Andrade, R. Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. Eur J Pharmacol. 1990; 182(3): 441–456.
56.Haddjeri, N, Blier, P, de Montigny, C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neursci. 1998; 18(23): 10150–10156.
57.Johnston, A, McBain, CJ, Fisahn, A. 5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation. J Physiol. 2014; 592(Pt 19): 4187–4199.
58.Kasamo, K, Suzuki, T, Tada, K, et al. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: in vivo electrophysiological evidence. Neuropsychopharmacology. 2001; 24(2): 141–151.
59.Tada, K, Kasamo, K, Suzuki, T, Matsuzaki, Y, Kojima, T. Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors. Hippocampus. 2004; 14(2): 143–147.
60.Llado-Pelfort, L, Santana, N, Ghisi, V, Artigas, F, Celada, P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cereb Cortex. 2012; 22(7): 1487–1497.
61.Haider, S, Khaliq, S, Tabassum, S, Haleem, DJ. Role of somatodendritic and postsynaptic 5-HT(1)A receptors on learning and memory functions in rats. Neurochem Res. 2012; 37(10): 2161–2166.
62.Newman-Tancredi, A, Martel, JC, Assie, MB, et al. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol. 2009; 156(2): 338–353.
63.Boschert, U, Amara, DA, Segu, L, Hen, R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience. 1994; 58(1): 167–182.
64.Bruinvels, AT, Landwehrmeyer, B, Gustafson, EL, et al. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 1994; 33(3–4): 367–386.
65.Sari, Y, Lefevre, K, Bancila, M, et al. Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain. Brain Res. 1997; 760(1–2): 281–286.
66.Bruinvels, AT, Palacios, JM, Hoyer, D. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(6): 569–582.
67.Xie, Z, Lee, SP, O’Dowd, BF, George, SR. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett. 1999; 456(1): 63–67.
68.Boeijinga, PH, Boddeke, HW. Serotonergic modulation of neurotransmission in the rat subicular cortex in vitro: a role for 5-HT1B receptors. Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(6): 553–557.
69.Mlinar, B, Falsini, C, Corradetti, R. Pharmacological characterization of 5-HT(1B) receptor-mediated inhibition of local excitatory synaptic transmission in the CA1 region of rat hippocampus. Br J Pharmacol. 2003; 138(1): 71–80.
70.Hu, XJ, Wang, FH, Stenfors, C, Ogren, SO, Kehr, J. Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: a microdialysis study. Eur Neuropsychopharmacol. 2007; 17(9): 580–586.
71.Bombardi, C. Neuronal localization of 5-HT2A receptor immunoreactivity in the rat hippocampal region. Brain Res Bull. 2012; 87(2–3): 259–273.
72.Cornea-Hebert, V, Riad, M, Wu, C, Singh, SK, Descarries, L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol. 1999; 409(2): 187–209.
73.Luttgen, M, Ove Ogren, S, Meister, B. Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res. 2004; 1010(1–2): 156–165.
74.Shen, RY, Andrade, R. 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther. 1998; 285(2): 805–812.
75.Wang, RY, Arvanov, VL. M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice. Brain Res. 1998; 779(1–2): 309–313.
76.Morales, M, Battenberg, E, de Lecea, L, Bloom, FE. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res. 1996; 731(1–2): 199–202.
77.Morales, M, Battenberg, E, de Lecea, L, Sanna, PP, Bloom, FE. Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system. Brain Res Mol Brain Res. 1996; 36(2): 251–260.
78.Bloom, FE, Morales, M. The central 5-HT3 receptor in CNS disorders. Neurochem Res. 1998; 23(5): 653–659.
79.Morales, M, Bloom, FE. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci. 1997; 17(9): 3157–3167.
80.Kawa, K. Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study. J Neurophysiol. 1994; 71(5): 1935–1947.
81.McMahon, LL, Kauer, JA. Hippocampal interneurons are excited via serotonin-gated ion channels. J Neurophysiol. 1997; 78(5): 2493–2502.
82.Dale, E, Zhang, H, Leiser, SC, et al. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. J Psychopharmacol. 2014; 28(10): 891–902.
83.Passani, MB, Pugliese, AM, Azzurrini, M, Corradetti, R. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br J Pharmacol. 1994; 112(2): 695–703.
84.Ropert, N, Guy, N. Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol. 1991; 441(1): 121–136.
85.Turner, TJ, Mokler, DJ, Luebke, JI. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies. Neuroscience. 2004; 129(3): 703–718.
86.Reznic, J, Staubli, U. Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat. J Neurophysiol. 1997; 77(1): 517–521.
87.Staubli, U, Otaky, N. Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses. Brain Res. 1994; 643(1–2): 10–16.
88.Staubli, U, Xu, FB. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci. 1995; 15(3 Pt 2): 2445–2452.
89.Vilaro, MT, Cortes, R, Mengod, G. Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol. 2005; 484(4): 418–439.
90.Waeber, C, Sebben, M, Nieoullon, A, Bockaert, J, Dumuis, A. Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology. 1994; 33(3–4): 527–541.
91.Peñas-Cazorla, R, Vilaró, MT. Serotonin 5-HT receptors and forebrain cholinergic system: receptor expression in identified cell populations. Brain Struct Funct. In press. DOI: 10.1007/s00429-014-0864-z.
92.Chapin, EM, Haj-Dahmane, S, Torres, G, Andrade, R. The 5-HT(4) receptor-induced depolarization in rat hippocampal neurons is mediated by cAMP but is independent of I(h). Neurosci Lett. 2002; 324(1): 1–4.
93.Mlinar, B, Mascalchi, S, Mannaioni, G, Morini, R, Corradetti, R. 5-HT4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons. Eur J Nneurosci. 2006; 24(3): 719–731.
94.Matsumoto, M, Togashi, H, Mori, K, et al. Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther. 2001; 296(3): 676–682.
95.Oliver, KR, Kinsey, AM, Wainwright, A, Sirinathsinghji, DJ. Localization of 5-ht(5A) receptor-like immunoreactivity in the rat brain. Brain Res. 2000; 867(1–2): 131–142.
96.Kinsey, AM, Wainwright, A, Heavens, R, Sirinathsinghji, DJ, Oliver, KR. Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. Brain Res Mol Brain Res. 2001; 88(1–2): 194–198.
97.Gerard, C, Martres, MP, Lefevre, K, et al. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 1997; 746(1–2): 207–219.
98.de Jong, I, Helboe, L. Distribution of serotonin receptor 5-HT6 mRNA in selected neuronal populations in rat brain: a double-labelling in situ hybridization study. Alzheimer’s & Dementia. 2014; 10(4 Suppl): 925–926.
99.West, PJ, Marcy, VR, Marino, MJ, Schaffhauser, H. Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience. 2009; 164(2): 692–701.
100.Schechter, LE, Lin, Q, Smith, DL, et al. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacol. 2008; 33(6): 1323–1335.
101.Dawson, LA, Nguyen, HQ, Li, P. The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology. 2001; 25(5): 662–668.
102.Pehrson, AL, Sanchez, C. Altered gamma-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des Devel Ther. 2015; 9: 603–624.
103.Wilkinson, D, Windfeld, K, Colding-Jorgensen, E. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer’s disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2014; 13(11): 1092–1099.
104.Neumaier, JF, Sexton, TJ, Yracheta, J, Diaz, AM, Brownfield, M. Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat. 2001; 21(1): 63–73.
105.Garcia-Alcocer, G, Segura, LC, Garcia Pena, M, Martinez-Torres, A, Miledi, R. Ontogenetic distribution of 5-HT2C, 5-HT5A, and 5-HT7 receptors in the rat hippocampus. Gene Expr. 2006; 13(1): 53–57.
106.Kobe, F, Guseva, D, Jensen, TP, et al. 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci. 2012; 32(9): 2915–2930.
107.Muneoka, KT, Takigawa, M. 5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive ‘stigmoid body’-like structure in developing rat brains. Int J Dev Neurosci. 2003; 21(3): 133–143.
108.Ciranna, L. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol. 2006; 4(2): 101–114.
109.Costa, L, Trovato, C, Musumeci, SA, Catania, MV, Ciranna, L. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Hippocampus. 2012; 22(4): 790–801.
110.Gill, CH, Soffin, EM, Hagan, JJ, Davies, CH. 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology. 2002; 42(1): 82–92.
111.Tokarski, K, Zahorodna, A, Bobula, B, Hess, G. 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res. 2003; 993(1–2): 230–234.
112.Tokarski, K, Kusek, M, Hess, G. 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J Physiol Pharmacol. 2011; 62(5): 535–540.
113.Gasbarri, A, Pompili, A. Serotonergic 5-HT7 receptors and cognition. Rev Neurosci. 2014; 25(3): 311–323.
114.Meneses, A. Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative. Rev Neurosci. 2014; 25(3): 325–356.
115.Chaput, Y, Lesieur, P, de Montigny, C. Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system. Synapse. 1990; 6(4): 328–337.
116.Ferraro, G, Montalbano, ME, Sardo, P, La Grutta, V. Lateral habenula and hippocampus: a complex interaction raphe cells-mediated. J Neural Transm. 1997; 104(6–7): 615–631.
117.Segal, M. Physiological and pharmacological evidence for a serotonergic projection to the hippocampus. Brain Res. 1975; 94(1): 115–131.
118.Segal, M. 5-HT antagonists in rat hippocampus. Brain Res. 1976; 103(1): 161–166.
119.Andrade, R, Chaput, Y. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther. 1991; 257(3): 930–937.
120.Piguet, P, Galvan, M. Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. J Physiol. 1994; 481(Pt 3): 629–639.
121.Cremers, TI, Rea, K, Bosker, FJ, et al. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology. 2007; 32(7): 1550–1557.
122.Haider, S, Khaliq, S, Ahmed, SP, Haleem, DJ. Long-term tryptophan administration enhances cognitive performance and increases 5HT metabolism in the hippocampus of female rats. Amino Acids. 2006; 31(4): 421–425.
123.Hervas, I, Artigas, F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur J Pharmacol. 1998; 358(1): 9–18.
124.Le Poul, E, Boni, C, Hanoun, N, et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology. 2000; 39(1): 110–122.
125.Blier, P, de Montigny, C, Chaput, Y. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry. 1990; 51(Suppl): 14–20; discussion 21.
126.Chaput, Y, de Montigny, C, Blier, P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology. 1991; 5(4): 219–229.
127.Malenka, RC, Nicoll, RA. Long-term potentiation—a decade of progress? Science. 1999; 285(5435): 1870–1874.
128.Corradetti, R, Ballerini, L, Pugliese, AM, Pepeu, G. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience. 1992; 46(3): 511–518.
129.Mnie-Filali, O, El Mansari, M, Espana, A, Sanchez, C, Haddjeri, N. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity. Neurosci Lett. 2006; 395(1): 23–27.
130.Ryan, B, Musazzi, L, Mallei, A, et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol. 2009; 12(4): 553–559.
131.Shakesby, AC, Anwyl, R, Rowan, MJ. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci. 2002; 22(9): 3638–3644.
132.Stewart, CA, Reid, IC. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl). 2000; 148(3): 217–223.
133.Pittenger, C, Duman, RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008; 33(1): 88–109.
134.Popoli, M, Gennarelli, M, Racagni, G. Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord. 2002; 4(3): 166–182.
135.Holderbach, R, Clark, K, Moreau, JL, Bischofberger, J, Normann, C. Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiatry. 2007; 62(1): 92–100.
136.Matsumoto, M, Tachibana, K, Togashi, H, et al. Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress. Psychopharmacology (Berl). 2005; 179(3): 606–612.
137.Godlewska, BR, Norbury, R, Selvaraj, S, Cowen, PJ, Harmer, CJ. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med. 2012; 42(12): 2609–2617.
138.Herzallah, MM, Moustafa, AA, Natsheh, JY, et al. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. J Affect Disord. 2013; 151(2): 484–492.
139.Olivier, B. Serotonin: a never-ending story. Eur J Pharmacol. 2015; 753: 2–18.
140.Kirchhoff, VD, Nguyen, HT, Soczynska, JK, Woldeyohannes, HO, McIntyre, RS. Discontinued psychiatric drugs in 2008. Expert Opin Investig Drugs. 2009; 18(10): 1431–1443.
141.Westrich, L, Pehrson, A, Zhong, H, et al. In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets. Int J Psych Clin Pract. 2012; 5(Suppl 1): 47.
142.Bang-Andersen, B, Ruhland, T, Jorgensen, M, et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem. 2011; 54(9): 3206–3221.
143.Katona, C, Hansen, T, Olsen, CK. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol. 2012; 27(4): 215–223.
144.McIntyre, RS, Lophaven, S, Olsen, CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014; 17(10): 1557–1567.
145.Mahableshwarkar, AR, Zajecka, J, Jacobson, W, Chen, Y, Keefe, RS. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015; 40(8): 2025–2037.
146.Browning, M, Smith, J, Conen, S, et al. Vortioxetine reduces BOLD signal during performance of the N-Back task in subjects remitted from depression and healthy control participants. Neuropsychopharm. 2014; 39(Supplement 1): S480.
147.Sanchez, C, Asin, KE, Artigas, F. Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data. Pharmacol Ther. 2015; 145: 43–57.
148.Mork, A, Pehrson, A, Brennum, LT, et al. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther. 2012; 340(3): 666–675.
149.Pehrson, AL, Cremers, T, Betry, C, et al. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—a rat microdialysis and electrophysiology study. Eur Neuropsychopharmacol. 2013; 23(2): 133–145.
150.Puig, MV, Santana, N, Celada, P, Mengod, G, Artigas, F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb Cortex. 2004; 14(12): 1365–1375.
151.Riga, MS, Celada, P, Sanchez, C, Artigas, F. Cortical and hippocampal microcircuits involved in the mechanism of action of the new antidepressant drug vortioxetine. Neuropsychopharm. 2014; 39(Supplement 1): S632.
152.El Mansari, M, Lecours, M, Blier, P. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain. Psychopharmacology (Berl). 2015; 232(13): 2343–2352.
153.O’Mara, SM, Sanchez-Vives, MV, Brotons-Mas, JR, O’Hare, E. Roles for the subiculum in spatial information processing, memory, motivation and the temporal control of behaviour. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(5): 782–790.
154.Sari, Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev. 2004; 28(6): 565–582.
155.Smagin, G, Song, D, Budac, DP, Pehrson, A, Li, Y, Sanchez, C. Chronic treatment with vortioxetine activates the central histaminergic system: a microdialysis study in rats. Biol Psychiatry. 2014; 75(9), Supplement, 391S.
156.Li, Y, Abdourahman, A, Tamm, JA, et al. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice. Pharmacol Biochem Behav. 2015; 135: 70–82.
157.Bétry, C, Etiévant, A, Pehrson, A, Sanchez, C, Haddjeri, N. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory. Prog Neuropsychopharmacol Biol Psychiatry. 2015; 58: 38–46.
158.Guilloux, JP, Mendez-David, I, Pehrson, A, et al. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 2013; 73: 147–159.
159.Sanacora, G, Banasr, M. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry. 2013; 73(12): 1172–1179.
160.Sanacora, G, Treccani, G, Popoli, M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012; 62(1): 63–77.
161.Pehrson, AL, Sanchez, C. Vortioxetine reverses social recognition memory impairments induced by acetylcholine or glutamate dysregulation in rats. Eur Neuropsychopharmacol. 2014; 24(Supplement 2): S369.
162.Bétry, C, Pehrson, AL, Etiévant, A, Ebert, B, Sánchez, C, Haddjeri, N. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. Int J Neuropsychopharmacol. 2013; 16(5): 1115–1127.
163.Pompeiano, M, Palacios, JM, Mengod, G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res. 1994; 23(1–2): 163–178.
164.Haider, S, Khaliq, S, Haleem, DJ. Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep. 2007; 59(1): 53–57.
165.Levkovitz, Y, Richter-Levin, G, Segal, M. Effect of 5-hydroxytryptophane on behavior and hippocampal physiology in young and old rats. Neurobiol Aging. 1994; 15(5): 635–641.
166.Egashira, N, Mishima, K, Katsurabayashi, S, et al. Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol. 2002; 445(3): 221–229.
167.Inoue, T, Kitaichi, Y, Koyama, T. SSRIs and conditioned fear. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35(8): 1810–1819.
168.Karabeg, MM, Grauthoff, S, Kollert, SY, et al. 5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze. PloS one. 2013; 8(10): e78238.
169.Nonkes, LJ, de Pooter, M, Homberg, JR. Behavioural therapy based on distraction alleviates impaired fear extinction in male serotonin transporter knockout rats. J Psychiatry Neurosci. 2012; 37(4): 224–230.
170.Luoni, A, Hulsken, S, Cazzaniga, G, Racagni, G, Homberg, JR, Riva, MA. Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats. Int J Neuropsychopharmacol. 2013; 16(6): 1319–1330.
171.Ampuero, E, Stehberg, J, Gonzalez, D, et al. Repetitive fluoxetine treatment affects long-term memories but not learning. Behav Brain Res. 2013; 247: 92–100.
172.Sass, A, Wortwein, G. The effect of subchronic fluoxetine treatment on learning and memory in adolescent rats. Behav Brain Res. 2012; 228(1): 169–175.
173.Gumuslu, E, Mutlu, O, Sunnetci, D, et al. The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice. Drug Res. 2013; 63(10): 532–539.
174.Valluzzi, JA, Chan, K. Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks. Behav Pharmacol. 2007; 18(5–6): 507–513.
175.Heinen, M, Hettich, MM, Ryan, DP, Schnell, S, Paesler, K, Ehninger, D. Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome. Neural Plasticity. 2012; 2012: Article 467251.
176.Myint, AM, O’Mahony, S, Kubera, M, et al. Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. J Psychopharmacol. 2007; 21(8): 843–850.
177.Wang, Y, Neumann, M, Hansen, K, et al. Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. J Neurotrauma. 2011; 28(2): 259–268.
178.Naudon, L, Hotte, M, Jay, TM. Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology (Berl). 2007; 191(2): 353–364.
179.Egashira, N, Matsumoto, Y, Mishima, K, et al. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacol Biochem Behav. 2006; 83(1): 161–167.
180.Montezinho, LP, Miller, S, Plath, N, et al. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine. Psychopharmacology (Berl). 2010; 212(2): 131–143.
181.Bridoux, A, Laloux, C, Derambure, P, Bordet, R, Monaca Charley, C. The acute inhibition of rapid eye movement sleep by citalopram may impair spatial learning and passive avoidance in mice. J Neural Transm. 2013; 120(3): 383–389.
182.Jensen, JB, du Jardin, KG, Song, D, et al. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation. Eur Neuropsychopharmacol. 2014; 24(1): 148–159.
183.Mørk, A, Montezinho, LP, Miller, S, et al. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Pharmacol Biochem Behav. 2013; 105: 41–50.
184.du Jardin, KG, Jensen, JB, Sanchez, C, Pehrson, AL. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism. Eur Neuropsychopharmacol. 2014; 24(1): 160–171.
185.Adams, W, Kusljic, S, van den Buuse, M. Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology. 2008; 55(6): 1048–1055.
186.Lehmann, O, Bertrand, F, Jeltsch, H, et al. 5,7-DHT-induced hippocampal 5-HT depletion attenuates behavioural deficits produced by 192 IgG-saporin lesions of septal cholinergic neurons in the rat. Eur J Neurosci. 2002; 15(12): 1991–2006.
187.Lehmann, O, Jeltsch, H, Lazarus, C, Tritschler, L, Bertrand, F, Cassel, JC. Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study. Pharmacol Biochem Behav. 2002; 72(4): 899–912.
188.Lehmann, O, Jeltsch, H, Lehnardt, O, Pain, L, Lazarus, C, Cassel, JC. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur J Neurosci. 2000; 12(1): 67–79.
189.Murtha, SJ, Pappas, BA. Neurochemical, histopathological and mnemonic effects of combined lesions of the medial septal and serotonin afferents to the hippocampus. Brain Res. 1994; 651(1–2): 16–26.
190.Volpe, BT, Hendrix, CS, Park, DH, Towle, AC, Davis, HP. Early post-natal administration of 5,7-dihydroxytryptamine destroys 5-HT neurons but does not affect spatial memory. Brain Res. 1992; 589(2): 262–267.
191.Gutierrez-Guzman, BE, Hernandez-Perez, JJ, Lopez-Vazquez, MA, Fregozo, CS, Guevara, MA, Olvera-Cortes, ME. Serotonin depletion of supramammillary/posterior hypothalamus nuclei produces place learning deficiencies and alters the concomitant hippocampal theta activity in rats. Eur J Pharmacol. 2012; 682(1–3): 99–109.
192.Richter-Levin, G, Greenberger, V, Segal, M. The effects of general and restricted serotonergic lesions on hippocampal electrophysiology and behavior. Brain Res. 1994; 642(1–2): 111–116.
193.Kenton, L, Boon, F, Cain, DP. Combined but not individual administration of beta-adrenergic and serotonergic antagonists impairs water maze acquisition in the rat. Neuropsychopharmacology. 2008; 33(6): 1298–1311.
194.Galani, R, Berthel, MC, Lazarus, C, et al. The behavioral effects of enriched housing are not altered by serotonin depletion but enrichment alters hippocampal neurochemistry. Neurobiol Learn Mem. 2007; 88(1): 1–10.
195.Lieben, CK, van Oorsouw, K, Deutz, NE, Blokland, A. Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat. Behav Brain Res. 2004; 151(1–2): 53–64.
196.Uchida, S, Umeeda, H, Kitamoto, A, Masushige, S, Kida, S. Chronic reduction in dietary tryptophan leads to a selective impairment of contextual fear memory in mice. Brain Res. 2007; 1149: 149–156.
197.Dai, JX, Han, HL, Tian, M, et al. Enhanced contextual fear memory in central serotonin-deficient mice. Proc Natl Acad Sci U S A. 2008; 105(33): 11981–11986.
198.Bert, B, Dere, E, Wilhelmi, N, et al. Transient overexpression of the 5-HT1A receptor impairs water-maze but not hole-board performance. Neurobiol Learn Mem. 2005; 84(1): 57–68.
199.Bert, B, Voigt, JP, Kusserow, H, Theuring, F, Rex, A, Fink, H. Increasing the number of 5-HT(1A)-receptors in cortex and hippocampus does not induce mnemonic deficits in mice. Pharmacol Biochem Behav. 2009; 92(1): 76–81.
200.Wolff, M, Costet, P, Gross, C, Hen, R, Segu, L, Buhot, MC. Age-dependent effects of serotonin-1A receptor gene deletion in spatial learning abilities in mice. Brain Res Mol Brain Res. 2004; 130(1–2): 39–48.
201.Klemenhagen, KC, Gordon, JA, David, DJ, Hen, R, Gross, CT. Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology. 2006; 31(1): 101–111.
202.Malá, H, Arnberg, K, Chu, D, Nedergaard, SK, Witmer, J, Mogensen, J. Only repeated administration of the serotonergic agonist 8-OH-DPAT improves place learning of rats subjected to fimbria-fornix transection. Pharmacol Biochem Behav. 2013; 109: 50–58.
203.Winter, JC, Petti, DT. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory. Pharmacol Biochem Behav. 1987; 27(4): 625–628.
204.Helsley, S, Siegel, TL, Fiorella, D, Rabin, RA, Winter, JC. WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze. Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(7): 1179–1184.
205.Egashira, N, Yano, A, Ishigami, N, et al. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats. Brain Res. 2006; 1069(1): 54–62.
206.Inui, K, Egashira, N, Mishima, K, et al. The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats. Neurotox Res. 2004; 6(2): 153–158.
207.Buhot, MC, Patra, SK, Naili, S. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur J Pharmacol. 1995; 285(3): 221–228.
208.Bauer, EP. Serotonin in fear conditioning processes. Behav Brain Res. 2015; 277c: 68–77.
209.Youn, J, Misane, I, Eriksson, TM, et al. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities. Neuropharmacology. 2009; 57(5–6): 567–576.
210.Hirst, WD, Andree, TH, Aschmies, S, et al. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405). J Pharmacol Exp Ther. 2008; 325(1): 134–145.
211.McDevitt, RA, Hiroi, R, Mackenzie, SM, et al. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol Psychiatry. 2011; 69(8): 780–787.
212.Wolff, M, Savova, M, Malleret, G, Hen, R, Segu, L, Buhot, MC. Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation. Neurosci Lett. 2003; 338(1): 1–4.
213.Malleret, G, Hen, R, Guillou, JL, Segu, L, Buhot, MC. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci. 1999; 19(14): 6157–6168.
214.Ahlander-Luttgen, M, Madjid, N, Schott, PA, Sandin, J, Ogren, SO. Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat. Neuropsychopharmacology. 2003; 28(9): 1642–1655.
215.Fedotova, YO, Ordyan, NE. Blockade of 5-HT2A/2C-type receptors impairs learning in female rats in the course of estrous cycle. Bull Exp Biol Med. 2010; 150(1): 6–8.
216.Naghdi, N, Harooni, HE. The effect of intrahippocampal injections of ritanserin (5HT2A/2C antagonist) and granisetron (5HT3 antagonist) on learning as assessed in the spatial version of the water maze. Behav Brain Res. 2005; 157(2): 205–210.
217.Levin, E, Icenogle, L, Farzad, A. Ketanserin attenuates nicotine-induced working memory improvement in rats. Pharmacol Biochem Behav. 2005; 82(2): 289–292.
218.Cohen, H. Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein. Depress Anxiety. 2005; 22(2): 84–93.
219.Zhang, G, Ásgeirsdóttir, HN, Cohen, SJ, Munchow, AH, Barrera, MP, Stackman, RW Jr. Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice. Neuropharmacology. 2013; 64: 403–413.
220.Tecott, LH, Logue, SF, Wehner, JM, Kauer, JA. Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc Natl Acad Sci U S A. 1998; 95(25): 15026–15031.
221.Burghardt, NS, Bush, DE, McEwen, BS, LeDoux, JE. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry. 2007; 62(10): 1111–1118.
222.Hodges, H, Sowinski, P, Sinden, JD, Netto, CA, Fletcher, A. The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. Psychopharmacology (Berl). 1995; 117(3): 318–332.
223.Pitsikas, N, Brambilla, A, Borsini, F. Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task. Pharmacol Biochem Behav. 1994; 47(1): 95–99.
224.Harrell, AV, Allan, AM. Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice. Learn Mem. 2003; 10(5): 410–419.
225.Segu, L, Lecomte, MJ, Wolff, M, et al. Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice. PloS one. 2010; 5(3): e9529.
226.Cachard-Chastel, M, Devers, S, Sicsic, S, et al. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behav Brain Res. 2008; 187(2): 455–461.
227.Orsetti, M, Dellarole, A, Ferri, S, Ghi, P. Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat. Learn Mem. 2003; 10(5): 420–426.
228.Fontana, DJ, Daniels, SE, Wong, EH, Clark, RD, Eglen, RM. The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology. 1997; 36(4–5): 689–696.
229.Woolley, ML, Bentley, JC, Sleight, AJ, Marsden, CA, Fone, KC. A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology. 2001; 41(2): 210–219.
230.Rogers, DC, Hagan, JJ. 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl). 2001; 158(2): 114–119.
231.Stean, TO, Hirst, WD, Thomas, DR, et al. Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist. Pharmacol Biochem Behav. 2002; 71(4): 645–654.
232.Lindner, MD, Hodges, DB Jr., Hogan, JB, et al. An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther. 2003; 307(2): 682–691.
233.Roberts, AJ, Hedlund, PB. The 5-HT(7) receptor in learning and memory. Hippocampus. 2012; 22(4): 762–771.
234.Gasbarri, A, Cifariello, A, Pompili, A, Meneses, A. Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav Brain Res. 2008; 195(1): 164–170.